Health & Biotech
Healthy snacks: Forbidden Foods gains traction in US with Blue Dinosaur brand
ASX Health Stocks: All about closing deals this morning as HeraMED and Careteq sign new contracts
ASX Health Stocks: Clarity to expand Phase 3 trial sites; CSL downgrades profit on FX headwinds
Bioxyne positions for growth following Breathe Life Sciences acquisition
The Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreak
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks lower, Sigma wins back Chemist Warehouse deal from EBOS
PharmAust begins Cohort 3 dosing in Phase 1/2 motor neurone disease trial
Creso Pharma to source high-quality Swiss psychedelics products for Australian market
ASX Health Stocks: Anteris’ 3D heart valve shows consistent results; as Nyrada announces a new lead drug
ASX Health Stocks: Avita jumps 14pc on FDA approval; Emyria to start trial on landmark MDMA therapy
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
PharmAust flags ‘steady state’ levels in Motor Neurone Disease clinical trial
ASX Health Stocks: Polynovo surges on sales; Pacific Edge wiped out 60pc after losing Medicare coverage
4D Medical’s technology disrupts century-old procedures AND makes over 90pc profit margin
ASX Health Stocks: Memphasys says Felix can separate sperm better than current techniques
EZZ looks to Vietnam for growth after returning from Vietbaby exhibition
Dimerix raises $8.7 million to advance Phase 3 trial for kidney drug
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
